Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 371M | 348M | 352M | 303M | 276M | 300M |
| Cost of revenue | 281M | 271M | 278M | 229M | 207M | 223M |
| Gross profit | 90M | 77M | 74M | 74M | 69M | 77M |
| Research and development | 11M | 10M | 10M | 10M | 10M | 10M |
| Selling, general and administrative | 72M | 60M | 60M | 57M | 53M | 55M |
| Operating income | 5M | 7M | 4M | 7M | 7M | 13M |
| Pre-tax income | 10M | 12M | 5M | 5M | 6M | 13M |
| Income tax | −2M | 3M | 2M | 900,000 | 3M | 5M |
| Net income | 12M | 9M | 3M | 5M | 3M | 8M |
| Earnings per share | 0.07 | 0.05 | 0.02 | 0.03 | 0.02 | 0.05 |
| Earnings per share, diluted | 0.07 | 0.05 | 0.02 | 0.03 | 0.02 | 0.05 |
| Weighted average shares | 177M | 171M | 156M | 154M | 153M | 152M |
| Weighted average shares, diluted | 179M | 173M | 157M | 156M | 154M | 154M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.46B | 561M | 566M | 784M | 264M | 329M | 302M | 308M |
| Receivables | 195M | 165M | 136M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −27M | — | — | −29M | — | — |
| Depreciation and amortisation | 17M | 12M | 12M | 10M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 142M |
| 118M |
| 118M |
| 113M |
| 132M |
| Current assets | 2.31B | 1.26B | 1.24B | 1.43B | 864M | 872M | 838M | 851M |
| Goodwill | 884M | 596M | 595M | 599M | 597M | 569M | 569M | 569M |
| Total assets | 4.04B | 2.47B | 2.42B | 2.59B | 2.00B | 1.95B | 1.91B | 1.91B |
| Current liabilities | 411M | 311M | 287M | 322M | 305M | 297M | 261M | 272M |
| Long-term debt | — | 0 | 0 | 170M | 172M | 175M | 177M | 180M |
| Total liabilities | 633M | 471M | 442M | 626M | 617M | 598M | 570M | 585M |
| Equity | 3.41B | 2.00B | 1.98B | 1.96B | 1.39B | 1.35B | 1.34B | 1.33B |
| Shares outstanding | 187M | 169M | 169M | 169M | 153M | 151M | 151M | 151M |
| Shares issued | 187M | 169M | 169M | 169M | 153M | 151M | 151M | 151M |
| 10M |
| 10M |
| Share-based compensation | 15M | — | — | 9M | — | — |
| Capital expenditure | 20M | — | — | 23M | — | — |
| Investing cash flow | −365M | — | — | −23M | — | — |
| Financing cash flow | 1.30B | — | — | −15M | — | — |